Boletín sobre Seguridad de Medicamentos de Uso Humano. Noviembre de 2024

Side Effects of GLP-1 Drugs: What Doctors Should Know

Infants Exposed to Minoxidil May Develop Hypertrichosis

Transdermal Beats Oral Estrogen for CVD Safety of Hormone Therapy

The Sexual Side Effects of Hormones and Other Drugs

Women Largely Unaware of Anti-Seizure Med Risks, More Education Needed

Lithium Use During Pregnancy in 14 Countries

Perspectives on Diversion of Medications From Safer Opioid Supply Programs

Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020

Risk of Intracranial Hemorrhage Associated With Direct Oral Anticoagulation vs Antiplatelet Therapy. A Systematic Review and Meta-Analysis

Prioritizing Research on Social Determinants of Health—“Yes, and…”

Care Models to Improve Pain and Reduce Opioids Among Patients Prescribed Long-Term Opioid Therapy. The VOICE Randomized Clinical Trial

Drug Overdose Deaths Among Medicaid Beneficiaries

Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel

Muscle-Building Supplements May Lead Young Men to Steroids

Some With Osteoporosis Should Not Take Drug Holidays

Health Impacts of Micro- and Nanoplastics

Empagliflozin and the Risk of Retinopathy in Patients With Type 2 Diabetes

Aspirin for Secondary Prevention of Atherosclerosis—Evidence or Dogma?

Recommendations to Ensure Safety of AI in Real-World Clinical Care

Study protocol for a pilot randomised controlled trial of a virtually delivered behavioural intervention (ACTION) for adults with cancer at risk for opioid use disorder

Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel

GLP-1 Labels Don’t Reflect Trial Exclusions

US Government Turns to Retail Pharmacies to Improve Representation in Clinical Trials

Efectos sexuales secundarios de las hormonas y otros fármacos

Risk for Ischemic Optic Neuropathy From Glucagon-Like Peptide 1 Receptor Agonists Too Rare to be Detected

Changes in Postpartum Opioid Prescribing After Implementation of State Opioid Prescribing Limits

Researcher Explores Using AI to Overcome Language Barriers With Patients

Ocular Side Effects Common in Real-World Study of Cancer Tx

Viral reactivation and clinical outcomes in Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

Pharmacovigilance study of famciclovir in the Food and Drug administration adverse event reporting system database

Characteristics of the current situation of drug use in elderly patients with chronic diseases in Chongqing: A cross-sectional survey

Pharmacovigilance study of famciclovir in the Food and Drug administration adverse event reporting system database

Artificial Intelligence and Machine Learning Models for Predicting Drug-Induced Kidney Injury in Small Molecules

Machine learning models for coagulation dysfunction risk in inpatients administered β-lactam antibiotics

Trends of drug-resistant tuberculosis and risk factors to poor treatment-outcome: a database analysis in Littoral region-Cameroon, 2013–2022

Safety and Effectiveness of Naltrexone-Bupropion in Korean Adults with Obesity: Post-Marketing Surveillance Study

Efficacy and safety of tofacitinib in rheumatoid arthritis: Nine years of real‐world data

Psychotropic drug-induced adverse drug reactions in 462,661 psychiatric inpatients in relation to age: results from a German drug surveillance program from 1993–2016

Minimizing the risk of ethylene glycol and diethylene glycol poisoning in medications: A regulatory and pharmacopoeial response

Quantifying the potential contribution of drugs to the occurrence of acute kidney injury in patients with chronic kidney disease

Transformative Role of Artificial Intelligence in the Pharmaceutical Sector

Real-World Pharmacovigilance Study Identifies Drugs Linked to Hepatitis B Virus Reactivation

DEEPSIDE A DEEP LEARNING FRAMEWORK FOR DRUG SIDE EFFECT PREDICTION

El inspector de la ANSM y presidente del Comité de Oficiales de PIC/S, Jacques Morènas, protagonista del cuarto diálogo del 25 aniversario de la AEMPS

UN Meeting Highlights Antimicrobial Resistance “Epiphany”—Lack of Antibiotic Access Is a Key Driver

The Future of Pharmacovigilance: Using Data Science to Predict and Prevent Adverse Drug Reactions

ADA Advises Against Using Compounded GLP-1 RA Medications

Health Care Actions for Reducing Plastic Use and Pollution

The Promise and Perils of Diversity Action Plans for Clinical Trials

Diversity Action Plans in Clinical Trials

Pharmacy Closures and Anticonvulsant Medication Prescription Fills

The applications and advances of artificial intelligence in drug regulation: A global perspective

Post-marketing regulatory actions in Portugal—A retrospective analysis between 2013 and 2023

Legal and scientific deficiencies of drug advertisements on German television

Recent Advances in Omics, Computational Models, and Advanced Screening Methods for Drug Safety and Efficacy

Pharmacovigilance insights into drug-induced cystitis: analysis of FDA data from 2004 to 2024

Online Pharmacies in India and 3 massive problems!

Assessing real-world safety of plecanatide: a pharmacovigilance study based on the FDA adverse event reporting system

The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline

The enhanced national pharmacovigilance system implemented for COVID-19 vaccines in France: a 2-year experience report

Adverse events associated with oseltamivir and baloxavir marboxil in against influenza virus therapy: A pharmacovigilance study using the FAERS database

Diffuse lung diseases ascribed to drugs: a nationwide observational study over 37 years using the French pharmacovigilance database

Adverse Drug Reactions and Safety Profiles in Cardiovascular Drug Therapy: A Pharmacovigilance Analysis

A Pharmacovigilance Study on Psychotropic Agent-Induced Urinary Retention Using the Japanese Adverse Drug Event Report Database

Pharmacovigilance in Action: Utilizing VigiBase Data to Improve Clozapine Safety

A systematic review of efficacy and safety of newer drugs approved from 2016 to 2023 for the treatment of complicated urinary tract infections

Possible Adverse Effects (AEs) of Semaglutide (Ozempic) Administration for the Latest Investigation

Pharmacovigilance analysis of drug-induced hypobrinogenemia using the FDA Adverse Event Reporting System

Assessment of the supply chain vulnerabilities for the first tranche of the Union list of critical medicines: Technical report

Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications: A Randomized Pragmatic Trial

Gabapentinoids and Risk of Hip Fracture

Nurse Burnout and Patient Safety, Satisfaction, and Quality of Care. A Systematic Review and Meta-Analysis

Early Appropriate Antibiotic Use for CRE and MDR P. aeruginosa Infections: Epidemiology, Risk Factors, and Diagnostics

A critical pathway to reducing maternal, newborn and child mortality

As GLP-1 Use Surges, Clinicians Weigh Benefits and Risks

Dealing with adverse drug reactions in the context of polypharmacy using regression models

Systematic review and meta-analysis on effectiveness of strategies for enhancing adverse drug reaction reporting

Drug Prices Negotiated by Medicare vs US Net Prices and Prices in Other Countries

Assessing acute kidney injury risk after COVID vaccination and infection in a large cohort study

Global Risk of AKI and Tubulointerstitial Nephritis following Anticancer Drug Administration, 1967-2023: Long-Term Pharmacovigilance Analysis FR-PO038

Advances in nanomaterials for precision drug delivery: Insights into pharmacokinetics and toxicity

Signals of Possibly Persistent Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Disproportionality Analysis Using the EudraVigilance Database

Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines. A Randomized Clinical Trial

Perspective Chapter: Application of Artificial Intelligence in Pharmacovigilance Practices

A real-world study of denosumab-related hypocalcaemia based on the US food and Drug Administration Adverse Event Reporting System database

Safety of the contrast enhancement agent sulfur hexafluoride in ultrasound: Analysis of the Federal Drug Administration Adverse Event Reporting System database

Safety Profile of Biological Drugs in Clinical Practice: A Retrospective Pharmacovigilance Study

Effectiveness of an intervention to improve pharmacovigilance among selected government hospitals in a district of Sri Lanka

What are the unintended patient safety consequences of healthcare technologies? A qualitative study among patients, carers and healthcare providers

Advancing the management of maternal, fetal, and neonatal infection through harnessing digital health innovations

Using digital health technologies to optimise antimicrobial use globally

Serious adverse events reported with benzimidazole derivatives: A disproportionality analysis from the World Health Organization’s pharmacovigilance database

Drug risks associated with sarcopenia: a real-world and GWAS study

Isotretinoin and Suicide: Data Mining of the United States Food and Drug Administration Adverse Event Reporting System Database

Using multiple drug similarity networks to promote adverse drug event detection

Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase

Descriptive analysis of adverse events following immunization with oral cholera vaccine in Lebanon

Drug-related problems among pediatric intensive care units: prevalence, risk factors, and clinical pharmacists’ interventions

Reusability report: exploring the utility of variational graph encoders for predicting molecular toxicity in drug design

Anti-Cancer Drug-Induced Lyell’s Syndrome: A Series of Two Patients

The evolution of the Pharmacovigilance department in the pharmaceutical industry: results of an Italian national survey

Evaluating Sex-Biased Adverse Event-Associated Drugs to Improve Kidney Disease Drug Prioritization TH-PO116

Leukocytes telomere length as a biomarker of adverse drug reactions induced by Osimertinib in advanced non-small cell lung cancer

Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review

Temporal trends in online searches related to COVID-19 vaccine safety: A digital infodemiology study

Clonazepam Recall Grows Over Potentially Life-Threatening Label Error

Eliminate Clozapine REMS, FDA Panels Say

Implementation Status and Challenges of Pharmacovigilance Program in Ethiopia: A Mixed-Methods Study

Deprescribing oral antidiabetics in elderly patients: Do electronic leaflets across the world address it?

Advances in drug-induced liver injury research: in vitro models, mechanisms, omics and gene modulation techniques

Views on the Development and Use of a New Digital Adverse Drug Event Reporting Platform in Australia: A Qualitative Study

Integrating electronic health records with other data sources for postmarket drug safety signal identification: a review

Association between different GLP-1 receptor agonists and acute pancreatitis: case series and real-world pharmacovigilance analysis

Implementation Status and Challenges of Pharmacovigilance Program in Ethiopia: A Mixed-Methods Study

Integrating electronic health records with other data sources for postmarket drug safety signal identification: a review

Emerging Technologies in the Pharmaceutical Supply Chains: A Systematic Review of Industry 5.0 Challenges

Boletín sobre Seguridad de Medicamentos de Uso Humano. Octubre de 2024

Exclusive-US FDA Finds Widely Used Asthma Drug Impacts the Brain

Governance of artificial intelligence and machine learning in pharmacovigilance: what works today and what more is needed?

Side Effects of GLP-1 Drugs: What Doctors Should Know

Integrating Big Data, Artificial Intelligence, and motion analysis for emerging precision medicine applications in Parkinson’s Disease

Risk-stratified treatment for drug-susceptible pulmonary tuberculosis

How to Stop Bone Loss After Denosumab? No Easy Answers

The Influence of Internet-Derived Misinformation on Medical Treatment Decisions: A Social Learning Perspective

Patient-centric decision-making in supplements intake and disclosure in clinical practice: a novel SIDP-12 tool to prevent drug–supplement interaction

Retrospective analysis of survival and safety of bevacizumab biosimilar and original drug combination chemotherapy in non-small cell lung cancer

The Impact of COVID-19 on RNA Therapeutics: A Surge in Lipid Nanoparticles and Alternative Delivery Systems

Web application for assisting non-dermatology physicians in learning and managing patients with common cutaneous adverse drug reactions: a multicenter randomized controlled trial

A Review on In Details of the Pharmacovigilance

Risks of malignancies related to disease-modifying antirheumatic drugs in rheumatoid arthritis: a pharmacovigilance analysis using the FAERS database

Safety Profile of Statins for Post-Marketing Adverse Cardiovascular Events: A Real-World Pharmacovigilance Analysis

Mendelian randomization and pharmacovigilance analyses reveal the causal relationship between antidiabetic drugs and psychiatric disorders

Polygenic risk score for drug-induced long QT syndrome: independent validation in a real-world patient cohort

Efficacy and safety of traditional Chinese medicine for the treatment of epilepsy by wind quenching and phlegm resolving: A systematic review and meta-analysis

The Post-Acute Covid-Vaccination Syndrome in the light of Pharmacovigilance

A modified Delphi exercise in physician-perceived risk factors for drug-induced pneumotoxicity in patients with rheumatological disease

Differences in Drug Shortages in the US and Canada

Ensuring Virtual Vigilance in Decentralized Clinical Trials

A real-world pharmacovigilance analysis of adverse events associated with irbesartan using the FAERS and JADER databases

Untapped Potential? Representativeness in Pragmatic Clinical Trials

Inappropriate antibiotic prescription for acute tonsillitis in low- and middle-income countries (LMICs): a systematic review and meta-analysis protocol

Evaluation of tolvaptan-associated hepatic disorder using different national pharmacovigilance databases

Informing the risk assessment related to lactation and drug exposure: A physiologically based pharmacokinetic lactation model for pregabalin

Drug-associated glaucoma: A real-world study based on the Food and Drug Administration adverse event reporting system database

A real-world pharmacovigilance study of FDA adverse event reporting system events for Lutetium-177-PSMA-617

Machine learning driven bioequivalence risk assessment at an early stage of generic drug development

Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system

Ginkgo biloba extract safety: Insights from a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events

Knowledge, Attitude, and Practice Regarding Pharmacovigilance and Barriers to Reporting Adverse Drug Reactions Among the General Population in Saudi Arabia

Lichenoid Drug Eruption Secondary to Systemic Antibiotics: Case Report

Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir

Pharmacovigilance monitoring and treatment adherence in patients on antihypertensive drugs at a tertiary care centre

Proactive therapeutic drug monitoring of biologic drugs in patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis: systematic review and meta-analysis

Uma breve revisão sobre Farmacovigilância: histórico, conceitos, aplicações e resoluções norteadoras

Adverse Drug Reactions to β-Lactam Antibiotics: A Portuguese Pharmacovigilance Database Analysis

Exploring drug-induced toxic epidermal necrolysis: A case series and comprehensive review

Posición de la Academia Nacional de Medicina respecto a la disposición de la ANMAT que cataloga a los inhibidores de la bomba de protones (IBP) como de “venta libre”

Developing a Screening Strategy to Identify Hepatotoxicity and Drug Interaction Potential of Botanicals

Exploring the influencing factors of adverse drug reaction reporting among medical personnel: a COM-B model-based study

Exploring Human Misuse and Abuse of Veterinary Drugs: A Descriptive Pharmacovigilance Analysis Utilising the Food and Drug Administration’s Adverse Events Reporting System (FAERS)

The Food and Drug Administration's Safety Surveillance of Adverse Event Cases Involving Cannabinoid Hemp Products, 2019–2023

Influence of inpatient withdrawal treatment on drug safety in alcohol use disorder — a quasi-experimental pre-post study

Safety of infliximab and adalimumab in pediatric inflammatory bowel diseases: a real-world analysis from FAERS database

Can Pharmacovigilance Data Represent a Potential Tool for Early Detection of the Antibiotic Resistance Phenomenon?

Practices and awareness of pharmacovigilance in ALERT hospital, Addis Ababa, Ethiopia, a pilot study

General selection criteria for safety and patient benefit [XⅢ]: Comparing the formulation characteristics of brand-name and generic bifonazole creams

Comparative safety of different antibiotic regimens for the treatment of outpatient community-acquired pneumonia among otherwise healthy adults

Evaluating the impact of loperamide on irinotecan-induced adverse events: a disproportionality analysis of data from the World Health Organization pharmacovigilance database (VigiBase)

A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) for gemcitabine

ASSESMENT OF ATTITUDE AND PRACTICE TOWARDS ADVERSE DRUG REACTION REPORTING OF HEALTH PROFESSIONALS IN REPUBLIC OF NORTH MACEDONIA

Educate to Reduce Unnecessary Antibiotic Prescriptions

Using digital health technologies to optimise antimicrobial use globally

How Will Trump’s Government Impact Health Policy Abroad?

El PRAN celebra 10 años de retos y logros en su jornada anual por el Día Europeo para el Uso Prudente de los Antibióticos

Machine learning algorithms for prediction of measles one vaccination dropout among 12–23 months children in Ethiopia

Reassuring Data on GLP-1 RAs and Pancreatic Cancer Risk

FDA Updates GLP-1 Label With Pulmonary Aspiration Warning

First Trimester Tetracycline Exposure and Risk of Major Congenital Malformations

Collaborative Real-World Evidence Among Regulators: Lessons and Perspectives

Cardiovascular adverse events associated with triptans for treatment of migraine: a pharmacovigilance study of the FDA adverse event reporting system (FAERS)

DNA-Based Chemical Unclonable Functions for Cryptographic Anticounterfeit Tagging of Pharmaceuticals

Pharmacovigilance: the evolution of drug safety monitoring

Adverse drug reactions following treatment of latent tuberculosis infection: a linked national tuberculosis surveillance with claims database

Nirsevimab Resistance Mutations Rare in RSV, Study Shows

Does Antibiotic Use During Influenza Infection Worsen Lung Immunity?

Papel del Servicio de Seguimiento Farmacoterapéutico (SFT) de la farmacia comunitaria en la detección y resolución de reacciones adversas a estatinas vinculadas a posibles errores diagnósticos en pacientes mayores

Global burden of vaccine-associated Guillain-Barré syndrome over 170 countries from 1967 to 2023

Trends of drug shortages in China from 2018 to 2020: A retrospective observational study

Evaluation of β-Blocker-Induced Bradyarrhythmia Using an Analysis of the Japanese Adverse Drug Event Report Database

Cardiovascular adverse events associated with norepinephrine–dopamine reuptake inhibitors: a pharmacovigilance study of the FDA Adverse Event Reporting System

Causal Deep Learning for the Detection of Adverse Drug Reactions: Drug-Induced Acute Kidney Injury as a Case Study

Gabapentinoids and Risk of Hip Fracture

Argus Database Software: Revolutionizing Drug Safety and Pharmacovigilance

Digitalisation of Monitoring Side Effects Before, During and After COVID-19 Vaccines–Analysis of the Impact of the Pandemic on Reporting Side Effects in Republic of Croatia

Meta Analysis of Efficacy and Safety of Traditional Chinese Medicine Combined with Immunosuppressive Agents in the Treatment of IgA Nephropathy

Mutagenicity and genotoxicity evaluation of 15 nitrosamine drug substance-related impurities in human TK6 cells

Sex Differences of Fall-Risk-Increasing Drugs in the Middle-Aged and Elderly: A Pharmacovigilance Analysis of FDA Adverse Event Reporting System

Statistics and Studies on the Impact of Ineffective Medications in Patients

Communities That HEAL Intervention and Mortality Including Polysubstance Overdose Deaths: A Randomized Clinical Trial

Strategies to Help Patients Navigate High Prescription Drug Costs

The Impact of Cyberethics on Healthcare and Public Health Sector

A Clustering Ensemble Method for Drug Safety Signal Detection in Post-Marketing Surveillance

Securing Drug Traceability: Block chain-Enhanced Privacy Protection and Anti-Counterfeit Measures in Pharmaceutical Supply Chains

Availability of Medications for Opioid Use Disorder in US Psychiatric Hospitals

Las XIII Jornadas Nacionales de Farmacovigilancia celebradas por la AEMPS reúnen a más de 500 profesionales sanitarios

Use of real-world data sources to evaluate cancer treatments: current practice and future perspectives

A Prospective Study of the Medication Regimen Complexity Index and Hospitalization Due to Adverse Drug Reactions Among People Living with HIV

Global Differences and Risk Factors Influencing Drug Hypersensitivity Quality of Life: A Multi-Centre, Multi-ethnic Study of Drug Allergy Across Three Continents

Prevalence and factors associated with preventable drug-related emergency department visits (DREDp) in elderly patients

Seguridad de enantato de noretisterona y valerato de estradiol como método anticonceptivo en Perú

Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database

Combating Misinformation on Social Media Using Social Noise and Social Entropy as a Measure of Uncertainty

SURVEY OF KNOWLEDGE OF PHARMACOVIGILANCE AND ADVERSE DRUG REACTIONS REPORTING AMONG HEALTHCARE PROVIDERS IN ABUJA, NIGERIA

Drug-induced hyponatraemia and possible related signals: Analysis of 659 cases reported to the Spanish Pharmacovigilance System and disproportionality analysis

A study on user willingness to participate in an adverse drug event information sharing system

A real-world pharmacovigilance study of Ocrelizumab based on FAERS database

Adverse events associated with Tezepelumab: a safety analysis of clinical trials and a pharmacovigilance system

Quantification of the prevalence of harms in healthcare related to drug treatment: reflections regarding the use of definitions developed for other settings to estimate the magnitude of the problem

Exploration of the potential association between newer antiseizure medications and arrhythmias: Integrating pharmacovigilance and bioinformatics evidence

Retrospective Evaluation of the Prevalence and Drug Susceptibility of Candida Species and an Analysis of Risk Factors for Oral Candidiasis

Impact of educational intervention on sensitisation and ADR reporting among paramedics in a teaching hospital in north India

Diabetic adverse events associated with three commonly used statins: a disproportionality analysis based on the FDA adverse event reporting system database

Insights into Fracture Risk with Tenofovir and Entecavir: Evidence from Pharmacovigilance Data

FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine

Methylphenidate and Atomoxetine in Pregnancy and Possible Adverse Fetal Outcomes. A Systematic Review and Meta-Analysis

Doctors Caution Over Weight Loss Drug Link to Nurse's Death

UN Meeting Highlights Antimicrobial Resistance “Epiphany”—Lack of Antibiotic Access Is a Key Driver

Boletín sobre Seguridad de Medicamentos de Uso Humano. Septiembre de 2024

Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines. A Randomized Clinical Trial

La AEMPS recuerda las condiciones necesarias para la donación de medicamentos en las zonas afectadas por la DANA

Pharmacy Closures and Anticonvulsant Medication Prescription Fills

GLP-1 RAs Safe in the Perioperative Period: New Guidance

Neonatal Colonization With Antibiotic-Resistant Pathogens in Low- and Middle-Income Countries. A Systematic Review and Meta-Analysis

Explainable artificial intelligence (XAI) to find optimal in-silico biomarkers for cardiac drug toxicity evaluation

Online Marketing of Falsified Drugs in Ghana: Content Analysis of Selected Drugs on Social Media

DrugDAGT: a dual-attention graph transformer with contrastive learning improves drug-drug interaction prediction

Exploring the Artificial Intelligence and Its Impact in Pharmaceutical Sciences: Insights Toward the Horizons Where Technology Meets Tradition

Prescribing Pattern and Safety Profile of Biological Agents for Psoriasis in Real-World Practice: A Four-Year Calabrian Pharmacovigilance Analysis

Diagnosing and Treating ADHD in Adults. Balancing Individual Benefits and Population Risks

High-Risk Medications in Persons Living With Dementia. A Randomized Clinical Trial

Analysis on Innovation and Application of Anti-counterfeiting Technology of Printed Matter

Trends in Antidiabetic Drug Use and Safety of Metformin in Diabetic Patients with Varying Degrees of Chronic Kidney Disease from 2010 to 2021 in Korea: Retrospective Cohort Study Using the Common Data Model

Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine

Knowledge attitude and practice of pharmacovigilance among community pharmacy in India: a questionnaire study

Curcuma-Based Nutritional Supplements and Risk of Age-Related Macular Degeneration

Drug-induced myocarditis: a real-world pharmacovigilance study using the FDA adverse event reporting system database

Acute toxicity and anti-inflammatory activity of an improved traditional medicine developed in Burkina Faso

Risk of Inflammatory Central Nervous System Diseases After Tumor Necrosis Factor–Inhibitor Treatment for Autoimmune Diseases. A Systematic Review and Meta-Analysis

Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis. Analysis of 3 Phase 3 Randomized Clinical Trials Through 76 Weeks

Safety study on adverse events of zanubrutinib based on WHO-VigiAccess and FAERS databases

Analysis of rational prescription of medicines by village clinics: a repeated cross-sectional study of a province in eastern China

Inhaled Reliever Therapies for Asthma. A Systematic Review and Meta-Analysis

La AEMPS lanza la campaña #EsPopularPeroNoCiencia frente a las seudoterapias

FDA Okays Abuse-Deterrent Opioid for Severe Pain

Michigan Oncologist Charged in Scheme to Illegally Sell Cancer Drugs

Outpatient Antibiotic Use and Treatment Failure Among Children With Pneumonia

Cardiovascular Risks With SGLT2 Inhibitors in Clinical Practice Among Patients With Type 2 Diabetes

The African Medicines Agency and Medicines Regulation: Progress, challenges, and recommendations

Substance Use Disorders Crisis Intervention Training (CIT)

Prevalence of treatment-related adverse events (TRAEs) with antibody-drug conjugates in metastatic breast cancer patients: A systematic review and meta-analysis

Establishing a multi‐method approach for unprecedented detection and quantification of 13 genotoxic impurities (GTIs) in Apixaban drug substance through ultra-performance liquid chromatography (UPLC)

ENSURING DRUG SAFETY: A REVIEW OF PHARMACEUTICAL QUALITY ASSURANCE PRACTICES

Safety of Inclisiran: A Disproportionality Analysis from the EudraVigilance Database

Reducing Errors and Enhancing Efficiency: The Role of IoT in Automating Pharmaceutical Supply Chains

Risk factors and drug resistance of adult community-onset urinary tract infections caused by Escherichia coli-producing extended-spectrum β-lactamase in the Chongqing region, China: a retrospective case–control study

Improving patient safety and access to healthcare: The role of pharmacist-managed clinics in optimizing therapeutic outcomes

State Policies Regulating Law Enforcement Access to Prescription Drug Monitoring Program Testosterone Prescription Data

THE ROLE OF E-PRESCRIBING IN IMPROVING THE SAFETY AND ACCURACY OF DRUG PRESCRIPTIONS

Low-Dose Aspirin and Risk of Anaemia in Older Adults: Insights from a Danish Register-based Cohort Study

Estrategias de la vigilancia de los eventos adversos a la inmunización contra la COVID-19: Experiencia cubana

A cross-sectional study to determine the potential drug–drug interactions in patients with alcoholic liver disease in a tertiary care hospital

The Importance of Pharmacovigilance in the Polyherbal Sector: Challenges and Future Potential

Leveraging Real-World Evidence in Pharmacovigilance Reporting

Deep neural network-based detection of counterfeit products from smartphone images

Identifying and quantifying exposures involving counterfeit opioid analgesic products

Prediction of adverse drug reactions using demographic and non-clinical drug characteristics in FAERS data

Malaria vaccine rollout begins in Africa: the need to strengthen regulatory and safety surveillance systems in Africa

Adverse Drug Events by Sex After Adjusting for Baseline Rates of Drug Use

Perspective Chapter: Challenges and Possible Solutions of ADR Monitoring (Pharmacovigilance) in Low- and Middle-Income Countries

Misinformation about Sunscreens on Brazilian Social Networks: A Risk to Public Health

Therapeutic drug monitoring of linezolid in Chinese premature neonates: a population pharmacokinetic analysis and dosage optimization

Evaluation of drug-related problems identified and pharmaceutical interventions in the wards of a maternity hospital

Pancreatitis inducidas por fármacos: estudio de 38 pacientes

Adverse Event Profile Differences among Long-acting Gonadotropin-releasing hormone analogs: A Real-world, Pharmacovigilance Study

Adverse event profile of albumin-bound paclitaxel: a real-world pharmacovigilance analysis

FDA Announces Recall of More than 7000 Bottles of Duloxetine

La AEMPS anuncia los ganadores de la IV edición de los premios del Plan Nacional frente a la Resistencia a los Antibióticos

EU Program Aims to Ensure Safety for Pilots Who Use Insulin

Increasingly Popular Hormonal Contraceptive Linked to Breast Cancer

Exploring the community pharmacist's knowledge, attitude, and practices regarding adverse drug reactions and its reporting in the United Arab Emirates: a survey-based cross-sectional study

The Prevalent New‐User Design to Study Drug–Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia

Association between Polypharmacy and Adverse Events in Patients with Alzheimer’s Disease: An Analysis of the Japanese Adverse Drug Event Report Database (JADER)

Can Vaccines Slash Global Antibiotic Use? WHO Says Yes

Comparison of the efficacy and safety of low-dose antihypertensive combinations in patients with hypertension: protocol for a systematic review and network meta-analysis

Cognitive Decline and Antihypertensive Use: New Data

Global and Regional Burden of Vaccine-Associated Erythema Multiforme and their Related Vaccines, 1967–2023: An In-Depth Analysis of the World Health Organization Pharmacovigilance Database

Adverse reaction signals mining comparison of amiodarone and dronedarone: a pharmacovigilance study based on FAERS

Implementation Status and Challenges of Pharmacovigilance Program in Ethiopia: A Mixed-Methods Study

From Risk to Resilience: Uncovering Drug Recall Trends and Bolstering Safety Strategies

Exploring willingness to use adverse drug reaction reporting systems: a multicentre qualitative study in China based on the technology acceptance model and task-technology fit integration approach

Disproportionality analysis of reslizumab based on the FDA Adverse Event Reporting System

Oropharyngeal Adverse Events to Drugs and Vaccines: Pharmacovigilance Data From Italy (2019–2021)

Post-marketing safety concerns with rimegepant based on a pharmacovigilance study

Real-World Assessment of Psychotropic and Antiepileptic Drug Use During Pregnancy in Belgium: Trends, Predictors, and Comparative Risk of Congenital Anomalies (2010–2016)

¿Es hora de reconsiderar el uso prolongado de betabloqueantes tras un infarto?

For Bloodstream Infection, 7 Days of Antibiotics as Effective as 14

Algorithmovigilance, lessons from pharmacovigilance

Isotretinoin and Suicide: Data Mining of the United States Food and Drug Administration Adverse Event Reporting System Database

Adequacy of Pharmacovigilance Training in the Health Professional Training Institutions in Uganda: Training Gaps and Opportunities for Improvement

When Patient Voices Get Lost in Evidence Hierarchies: A Testimony of Rare Adverse Events and Participatory Epistemic Injustice in Drug Safety Monitoring

Time to major adverse drug reactions and its predictors among children on antiretroviral treatment at northwest Amhara selected public hospitals northwest; Ethiopia, 2023

“Before medically advised” hospital discharge and the risk of subsequent drug overdose: A case‐crossover analysis

Adverse Drug Reactions in an Ageing PopulaTion risk Prediction (ADAPTiP) tool: development of a prediction model related to hospital admissions

Pharmaceutical Logistics under Cyberattack Conditions

Social Media Exposure to Health Misinformation and Effect on Vaccination Intention and Behaviour

Enhancing medication errors detection and reporting through online learning Can an online course make a difference?

Efficacy and safety of higher dose rifampicin in adults with presumed drug-susceptible tuberculosis: an updated systematic review and meta-analysis

Safety assessment of drug impurities for patient safety: A comprehensive review

Efficacy and safety of vancomycin compared with those of alternative treatments for methicillin‐resistant Staphylococcus aureus infections: An umbrella review

Racial representation in multicenter clinical trials leading to drug approvals for gynecological cancer indications by the US Food and Drug Administration (FDA).

Comprehensive analysis of VEGF/VEGFR inhibitor-induced immune-mediated hypertension: integrating pharmacovigilance, clinical data, and preclinical models

MDDC: An R and Python Package for Adverse Event Identification in Pharmacovigilance Data

Safety challenges of AI in medicine

Artificial intelligence-powered chatbots in search engines: a cross-sectional study on the quality and risks of drug information for patients

A Concise Review on 3-D Printing Technology in Pharmaceutical Sciences

FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine

World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Participants

Declaration of Helsinki Addresses New Ethical Challenges

The 2024 Revision to the Declaration of Helsinki. Modern Ethics for Medical Research

Revisiting the Declaration of Helsinki—A Patient-Centered Perspective

Facilitating Efficient and Ethical Trials at the Intersection of Research and Clinical Care

The Revised Declaration of Helsinki—Considerations for the Future of Artificial Intelligence in Health and Medical Research

The Revision of the Declaration of Helsinki Viewed From the Americas—Paving the Way to Better Research

Future-Proofing Research Ethics—Key Revisions of the Declaration of Helsinki 2024

Revisions to the Declaration of Helsinki on Its 60th Anniversary. A Modernized Set of Ethical Principles to Promote and Ensure Respect for Participants in a Rapidly Innovating Medical Research Ecosystem

Making the Ethical Oversight of All Clinical Trials Fit for Purpose

Risk of Suicidal Ideation or Attempts in Adolescents With Obesity Treated With GLP1 Receptor Agonists

Antipsychotic Drugs and Cognitive Function. A Systematic Review and Pairwise Network Meta-Analysis

The Hidden Cost of Cancer Treatment: Time Toxicity

Use of Opioid Overdose Reversal Drug by Community Still Small Portion of Total Naloxone Administrations

Riding the waves of uncertainty: Towards strategic agility in medicine supply systems

The significance of therapeutic drug monitoring in detecting low medication adherence in patients with cancer: A case study of cabozantinib

Why a Diabetes Drug Fell Short of Anticancer Hopes

Adverse Effects and Contraindications of Sodium Bicarbonate Treatment

The Flu Vaccine Might Be Less Effective This Year

Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine

Public Health and Online Misinformation

La banalidad de la mentira. Su relación con la práctica médica

Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer

The Application of Machine Learning in Drug Discovery

Postmarketing adverse events of tamoxifen in male and female patients with breast cancer

The Role of AI in Combating Counterfeit Drugs

Developing large language models to detect adverse drug events in posts on x

Re-Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study

A critical need for ‘gut neutrality’: mitigating adverse drug–microbiome interactions

Las empleadas de la dependencia que soportan la precariedad a base de opioides: "La gente está agotada, quemada"

Taxonomía de la seguridad del paciente

Remedies for Menopause Symptoms Show Short-Term Benefit, Need Long-Term Data

Knowledge, attitudes, and practices of hospital pharmacists regarding clinically relevant drug interactions: A multi-center regional survey in Indonesia.

Antiseizure Medications and Cardiovascular Events in Older People With Epilepsy

Myth of the Month: Vitamin C vs the Common Cold

Adverse Drug Reactions in Psychiatry: An Alarming Scenario

Risks of oral anticoagulants: Analysis of adverse drug reactions reported to the Portuguese National Pharmacovigilance System

Botanical-induced toxicity: Liver injury and botanical-drug interactions. A report on a society of Toxicology Annual Meeting symposium

Incidence of Adverse Events Related to Therapies with sodium iodine (131I): Contribution to the Pharmacovigilance in Brazil

The Hidden Risks of Using Counterfeit Drugs

Adverse Drug Reactions During Intensive Phase of Treatment Among Multi-Drug Resistant Tuberculosis Cases Registered at a DR-TB Centre of Southern India

Suspected poor-quality medicines in Kenya: a retrospective descriptive study of medicine quality-related complaints reports in Kenya’s pharmacovigilance database

ADVERSE DRUG REACTION DUE TO COMBINATION OF AMOXICILLIN AND CLAVULANIC ACID ALONG WITH ITS CAUSALITY ASSESSMENT: A CASE REPORT

'Deb's Active Surveillance & Assisted Reporting System: A District Based Innovative Approach to Adverse Drug Reaction Monitoring

Evaluating Medical Students' Knowledge, Attitudes, and Practices in Pharmacovigilance: A Cross-Sectional Study

Safety and Efficacy of Drug-Eluting Stents Improved Dramatically with Application of Nanotechnology

Delayed drug hypersensitivity reactions: How p-i transforms pharmacology into immunology

Association of anxiolytic drugs with Torsade de Pointes: a pharmacovigilance study of the Food and Drug Administration Adverse Event Reporting System

Drug-Related Keratitis: A Real-World FDA Adverse Event Reporting System Database Study

Adverse Drug Reactions Resulting From the Use of Chiral Medicines Amoxicillin, Amoxicillin-Clavulanic Acid, and Ceftriaxone: A Mixed Prospective-Retrospective Cohort Study

The Proliferation And Impact Of Clandestine Drug Laboratories In India

Health risk assessment of heavy metals in Malay herbal medicine (MHM) consumed by pregnant and postpartum mothers

Antibiotics-induced pulmonary embolism: A disproportionality analysis in Food and Drug Administration database of Adverse Event Reporting System using data mining algorithms

Self-Reported Illicitly Manufactured Fentanyl Use and Associated Health and Substance Use Risks in the United States, 2022

High Drug Costs Influence Nonadherence to Medications Among Older Adults

Interpretable multitemporal liver function indicator model for prediction and risk factor analysis of drug induced liver injury

Stratified analysis of the association between anti-obesity medications and digestive adverse events: a real-world study based on the FDA adverse event reporting system database

High-risks drug adverse events associated with Cetirizine and Loratadine for the treatment of allergic diseases: A retrospective pharmacovigilance study based on the FDA adverse event reporting system database

Drug-Induced Gynecomastia: Data Mining and Analysis of the FDA Adverse Event Reporting System Database

Patients' Lack of Knowledge on Antibiotic Risks Drives Expectations

A pharmacovigilance study on clinical factors of active vitamin D3 analog-related acute kidney injury using the Japanese Adverse Drug Event Report Database

Promoting Patient Engagement in Adverse Drug Reaction Reporting: A Novel Approach Utilizing Set Induction-Based Skill Questionnaires

Communication Key to Improving Patient Safety

Adverse events associated with the use of radiopharmaceuticals: A prospective study from a tertiary care institute

Disproportionality analysis of amenamevir-induced encephalopathy using the Japanese adverse drug event report database

Audit of risk factors of drug-sensitive, drug-resistant tuberculosis disease, a case-control study of patients registered under NTEP, Gujarat

Mobile phone interventions to improve health outcomes among patients with chronic diseases: an umbrella review and evidence synthesis from 34 meta-analyses

Educate to Reduce Unnecessary Antibiotic Prescriptions

Pharmacovigilance of drug-drug interactions: A pharmacokinetic study on the combined oral administration of lurasidone and clozapine in rats by using LC-MS/MS

El Gobierno abandonó el informe que estudiaba la eficacia de la homeopatía

Clozapine and Respiratory Infection Risk: What to Know

The time to address the antibiotic pipeline and access crisis is now

Insulin Therapy De-Escalation to Fixed-Ratio Combo Safe

Fridays and Snacking Bad for Smart Insulin Pen Adherence

Genetic ancestry in Population Pharmacogenomics unravels distinct geographical patterns related to drug toxicity

Adverse drug reactions and drug-related problems with supportive care medications among the oncological population

Risk of Rhabdomyolysis Associated with Dexmedetomidine Use over the Past 10 Years: Insights from the EudraVigilance Database

Retinal vascular occlusion after COVID-19 vaccination: analysis of the French pharmacovigilance database

Promoting Patient Engagement in Adverse Drug Reaction Reporting: A Novel Approach Utilizing Set Induction-Based Skill Questionnaires

Safety Profile of Mass Administration of Albendazole Among School Children (6-19 Years): A Prospective Active Surveillance Study

ExDDI: Explaining Drug-Drug Interaction Predictions with Natural Language

Analysis of anticholinergic drugs associated with aspiration pneumonia using the Japanese adverse drug event report database: Supplementary insights from a scoping review

Understanding medicine related adverse events in people with multiple long-term conditions and polypharmacy

The Rise of Nanotechnology in Pharmaceutical and Healthcare Packaging: Applications and Future Prospective

Description of clinical pharmacists reported interventions to prevent adverse drug events among patients with cardiovascular disease in Qatar

Pregnancy related adverse events and congenital disorders associated with fluoroquinolones: A real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS)

Drug-Associated Acute Kidney Disease: Data From a World Pharmacovigilance Database

Relevance of Pharmacovigilance in Aquatic Animal Medicine. A Perspective from Aquaculture Health Experts Attending a Focus Group Meeting at the EMA

Abemaciclib increases the risk of venous thromboembolism in breast cancer: Integrate meta-analysis, pharmacovigilance database analysis, and in vitro validation

A real-world pharmacovigilance study of esketamine nasal spray

Analysis of publicly available adverse events reported for pediatric patients treated with Janus kinase inhibitors

Disproportionality Analysis of Osimertinib-related Adverse Events in Elderly Patients Using the Japanese Pharmacovigilance Database

From the mechanism of action to clinical management: A review of cardiovascular toxicity in adult treated with CAR-T therapy

Safety assessment of basiliximab using real-world adverse event data from the FDA Adverse Event Reporting System Database: A retrospective observational study

Efficacy and safety of an oral complementary medicine combination in people with symptomatic knee osteoarthritis: Protocol for the double-blind, randomized, placebo-controlled ATLAS trial

Leveraging Generative AI for Drug Safety and Pharmacovigilance

A Model for an Academia-Industry Collaboration for Pharmacovigilance and Pharmacoepidemiology

Localization of Pharmaceutical Manufacturing in Sub-Saharan Africa

Assessing the risk of tumor lysis syndrome associated with the use of antineoplastic agents: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database

Sorafenib safety evaluation: Real-world analysis of adverse events from the FAERS database

Informe de inteligencia artificial y medicina: resultados de los médicos españoles

AI in Predicting Adverse Drug Reactions: Enhancing Patient Safety

Increasing Mortality Rates in the US, but Not From COVID-19

Managing Drug-Drug Interactions—So Many Drugs, So Little Evidence

Drug-Drug Interactions and the Clinical Tolerability of Colchicine Among Patients With COVID- 19 A Secondary Analysis of the COLCORONA Randomized Clinical Trial

The role of artificial intelligence in revolutionizing personalized medicine: A comprehensive review of techniques and applications

Generative artificial intelligence and ethical considerations in health care: a scoping review and ethics checklist

Cutaneous Adverse Reactions to Apalutamide: Case Series with Clinical and Pathological Correlations

Ecofarmacovigilancia: el efecto de los medicamentos sobre el medio ambiente

Aspirin Discontinuation at 24 to 28 Weeks’ Gestation in Pregnancies at High Risk of Preterm Preeclampsia. A Randomized Clinical Trial

Suspected Adverse Drug Reactions of Rivaroxaban Reported in the United States Food and Drug Administration Adverse Event Reporting System Database: a pharmacovigilance study

Strategies to enhance risk communication about medicines in Malaysia: a Delphi study among multinational experts

Controlling Prescribing through “Preferred Drug” Targets—The Bavarian Experience

Cardiovascular Safety of Romosozumab Compared to Commonly Used Anti-osteoporosis Medications in Postmenopausal Osteoporosis: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials

New Approach Methodologies (NAMs) in Drug Safety Assessment: A Vision of the Future

Association of Clopidogrel with Interstitial Lung Disease: Gaining Insight Through the Japanese Pharmacovigilance Database

Comparative sensitivity of laboratory animals used for preclinical convulsion risk assessment to drug-induced convulsion

Misalignment between the evidence base and Scheme design

Risk of myocardial infarction in users of third generation oral contraceptives

Balancing Efficacy and Tolerability: Assessing Treatment Impact and Side Effects in Prescribing Decisions

Integration and development of veterinary Chinese medicine insight into the development of human Chinese medicine

Safety and Pharmacovigilance in Emergency Research Response

Assessment of drug therapy problems among hypertensive patients at integral institute of medical science and research

Concomitant Administration of Psychotropic and Prostate Cancer Drugs: A Pharmacoepidemiologic Study Using Drug–Drug Interaction Databases

Managing Drug-Drug Interactions and Contraindications with Cephalosporins

Global burden of ADHD medication-associated cardiovascular disease, 1967-2023: A comparative analysis using the WHO pharmacovigilance database

Radio frequency identification technology; A method of analysis of falsified pharmaceutical products: Literature review

Drug-induced liver injury associated with atypical generation antipsychotics from the FDA Adverse Event Reporting System (FAERS)

Off‑label and unapproved pediatric drug utilization: A meta‑analysis

Consumer Perceptions of Safety Information in Direct-to-Consumer Print Advertisements for Alzheimer Drugs

Drug exposure characteristics and related pregnancy outcomes in pregnant women: an observational cohort study

The impact of emergency medicine pharmacists on medication safety for critically ill patients in the resuscitation area of an emergency department: a pilot study

La importancia de la farmacovigilancia con enfoque en las enfermedades crónico degenerativas más comunes en México

Pancreatitis Associated With Teduglutide: A Disproportionality Analysis via the Food and Drug Administration Adverse Event Reporting System (FAERS) Database

A field-portable technology for illicit drug discrimination via deep learning of hybridized reflectance/fluorescence spectro-scopic fingerprints

The Rising Threat of Counterfeit GLP-1 Receptor Agonists: Implications for Public Health

In Vitro Assessment of Inhibitory Effects of Kinase Inhibitors on CYP2C9, 3A and 1A2: Prediction of Drug-Drug Interaction Risk with Warfarin and Direct Oral Anticoagulants

Global Perspective of the Risks of Falsified and Counterfeit Medicines: A Critical Review of the Literature

Long-term safety of zavegepant nasal spray for the acute treatment of migraine: A phase 2/3 open-label study

Efficacy and safety of current therapies for difficult-to-treat rheumatoid arthritis: a systematic review and network meta-analysis

From Botox Party to Botulism: A Case Report and Public Health Warning on Adulterated Botulinum Toxin Injection

Risk factors of passive suicidal ideation among outpatients in traditional medicine clinics: the case of Korean medicine in South Korea

Risk Factors Associated With Drug-Related Side Effects in Children: A Scoping Review

Real-World Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System Database for Asciminib

Pharmacy Accessibility and Social Vulnerability

Why the Rise of This Drug-Resistant Fungus Is Raising International Concern

Which Medications Can Cause Edema?

La AEMPS realizará a partir del 1 de septiembre todas las notificaciones a los laboratorios nacionales de medicamentos a través de la Sede Electrónica

Oral Antibiotics and Risk of Serious Cutaneous Adverse Drug Reactions

Oral Contraceptives and the Risk of Psychiatric Side Effects: A Review

Drug-Induced Hair Loss: Analysis of the Food and Drug AdministrationLs Adverse Events Reporting System Database

EMA Warns of Anaphylactic Reactions to MS Drug

Statins: So Misunderstood

Oral Antibiotics and Risk of Serious Cutaneous Adverse Drug Reactions

No-Prescription Online Semaglutide Poses Multiple Risks

Boletín sobre Seguridad de Medicamentos de Uso Humano. Mayo de 2024

Is Vaginal Estrogen Safe in Breast Cancer Survivors?

Rates of adverse events of antiretroviral therapy in women living with HIV/AIDS: a systematic review and meta-analysis

Measuring access to essential medicines in the sustainable development goals

Medication Optimization Protocol Efficacy for Geriatric Inpatients. A Randomized Clinical Trial

The incidence of heart attacks and strokes was lower after COVID-19 vaccination than before or without vaccination, according to a new study involving nearly the whole adult population of England.

Evaluation of the Med Safety mobile app for reporting adverse events in Burkina Faso

Donepezil as a safe alternative treatment after maculo-papular eruption related to rivastigmine in Lewy body disease: a case report and pharmacovigilance data

The Arduousness of Navigating the Drug Facts Label and Assessing Its Quality While Shopping OTC Drugs Online

Exploiting Question-Answer framework with multiGRU to detect Adverse Drug Reaction on social Media

Risk Factors and Drug Therapy Monitoring in CKD Patients (Chronic Kidney Disease)

Comprehensive analysis of cutaneous adverse drug reactions during hospitalization: unveiling nuanced complexities and ensuring patient safety

Methotrexate, Tofacitinib, and Biologic Disease-Modifying Antirheumatic Drug Safety and Effectiveness Among Patients with Rheumatoid Arthritis in Japan: CorEvitas Registry Observational Study

Boletín sobre Productos Sanitarios. Abril-junio de 2024

Boletín sobre Cosméticos, Biocidas AEMPS y Productos de Cuidado Personal. Abril-Junio de 2024

Identifying strategies to improve adverse drug reporting through key informant interviews among community pharmacists in a developing country

Clinical drug interactions between linezolid and other antibiotics: For adverse drug event monitoring

THE DANGER OF ORGANIZED CRIME IN THE AREA OF FALSIFICATION OF MEDICINES AND MEDICAL PRODUCTS (PROFIT VS. RIGHT TO HEALTH)